The forecast for the number of scientific publications among the world's top 10% cited in Immunology and Microbiology in China shows a steady increase from 1.2 thousand in 2024 to 1.59 thousand in 2028. Comparing this to 2023 data would provide critical context, but assuming growth from prior trends, notable percentage increases year-on-year point towards a strong upward trajectory. The compound annual growth rate (CAGR) for this period emphasizes consistent advancement in research prominence.
Future trends to watch for include advancements in research infrastructure and increased international collaborations, contributing to more significant citations in global platforms.
